Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Study Phase
Phase 3
Study Completion Date
July 2010
NCT00554229Uploaded 10-13-2015
Available for Download
PDS UID: Prostat_AstraZe_2009_144
A Phase III Trial to Test the Efficacy of ZD4054(Zibotentan), an Endothelin A Receptor Antagonist, Versus Placebo in Patients With Hormone Resistant Prostate Cancer (HRPC) and Bone Metastasis Who Are Pain Free and Mildly Symptomatic.
PDS UID: Prostat_Multipl_2009_417Go to Study
Enhancing the Analytic Capacity of Prostat_AstraZe_2009_144 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
PROTOCOLClinical Study Protocol redacted.pdf
CRFSample CRF Version 78 5.pdf
DATA DICTIONARYDe indentification RDB standards STUDY14.xlsx
DATA (COMPARATOR ARM)D4320C00014 De-Identified RDB
OtherD4320C00014 Format